Outcome base rates
What's normal — PI grant rate, infringement rate, revocation rate, settlement rate. Honest denominators using motion type.
Patentee win rate
Share of merits decisions where the patentee prevailed — infringement cases finding infringement, revocation cases upholding the patent. Settled, withdrawn, and procedural-only outcomes excluded from the denominator.
No merits decisions in the current scope.
PI grant rate
—
PI grant rate (conservative)
—
Infringement rate
—
Revocation rate
—
Settlement / withdrawal rate
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
83% 15 / 18
Settlement timing
When settled or withdrawn cases actually closed — relative to procedural milestones.
By technology sector
Top sectors by case count (filter scope applied).
By case category
How outcome rates differ across the six L2 buckets.
- Procedural & sub-applications43
By division
PI grant rate · infringement rate · revocation rate per division (within scope).
- Court of Appeal43 casesPI grant rate: —Infringement rate: —Revocation rate: —
Recent decisions
Most recent decisions in scope.
- 2025-12-24UPC_APP_20809/2025Court of AppealSettledThe Court of Appeal permitted Sumi Agro Limited and Sumi Agro Europe Limited's withdrawal of their application for rehearing (R. 245 RoP) in the appeal UPC_CoA_523/2024, filed following ongoing settlement discussions between the parties. Both parties jointly applied for the withdrawal, agreed that no costs would be claimed, and requested release of the security deposit. The proceedings were declared closed.
- 2025-09-23UPC_APP_33679/2025Court of AppealProcedural onlyCourt of Appeal admitted Apple Inc.'s applications to intervene in the appeal proceedings (Ericsson v. ASUS) concerning confidentiality orders relating to licensing agreements between Ericsson and Apple. The CoA held that Apple has a direct and present legal interest in the result of the proceedings under R.313.1 RoP, as the confidential information at issue concerns Apple–Ericsson agreements. Apple was granted 15 days to file a Statement in intervention and will be permitted to participate in the oral hearing.
- 2025-08-25UPC_APP_34972/2025Court of AppealProcedural onlyThe Court of Appeal rejected Sun Patent Trust's application for suspensive effect of its appeal against a Paris Local Division order, finding that granting VIVO employees access to highly confidential information pending the appeal did not irreversibly undermine the appeal's purpose.
- 2025-08-25UPC_APP_34971/2025Court of AppealProcedural onlyThe Court of Appeal received Sun Patent Trust's application for suspensive effect under Rule 223 RoP against an order of the Paris Local Division of 31 July 2025 granting certain Vivo employees access to highly confidential information in infringement proceedings. Sun Patent argued that the highly confidential licence information should be subject to an 'External Eyes Only' regime excluding Vivo employees.
- 2025-08-21ORD_35283/2025Court of AppealProcedural onlyOrder from the Court of Appeal (UPC_CoA_363/2025) dismissing Microsoft's request for rectification of a Court of Appeal decision by default against Suinno Mobile & AI Technologies under R. 353 RoP. Microsoft sought to add a R. 356.3 RoP notice (that a further default decision would be final) to the decision. The Court held that such a notice must be requested in the proceedings concerning the default decision itself, and could not be added retrospectively by way of rectification.
- 2025-08-12UPC_APP_33761/2025Court of AppealProcedural onlyCourt of Appeal (12 August 2025) extended the deadline for Cisco to file its response to Lionra's appeal and any cross-appeal by two weeks (to 3 October 2025), finding a full month extension too long and one week too short given that Cisco had only recently obtained access to Lionra's unredacted appeal grounds (which contained confidential source code material).
- 2025-07-03UPC_APP_25615/2025Court of AppealWithdrawnThe Court of Appeal permitted the withdrawal by Advanced Bionics AG of both its revocation action and the counterclaim for revocation against MED-EL, with both parties' consent, declared the proceedings closed, and ordered 60% reimbursement of court fees to each side.
- 2025-07-03UPC_APP_25616/2025Court of AppealWithdrawnThe Court of Appeal ruled on Advanced Bionics' withdrawal of two appeals, holding that separate court fees are required for appeals against revocation decisions and counterclaim for revocation decisions even when issued in a single document by the Court of First Instance.